Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis

The Cyclosporine and FK506 (tacrolimus)-series have been utilized in a chemically slightly altered form as immunosuppressant medications for a long time. Both suppress the cellular immune defenses. This effect is necessary in conjunction with organ transplants, but otherwise problematic for the organism. The specific combination of the two substances amplifies the protective effect on the nerve cells thanks to different but synergistic efficacy mechanisms. The impact on the immune defense is reduced at the same time, which results in fewer side effects

Read more at: http://medicalxpress.com/news/2012-11-combination-pharmaceuticals-effective-treatment-multiple.html#jCp